Rarity PBC

Los Angeles, California, United States · Biotechnology, Health Care · 5 employees

Rarity PBC is a Public Benefit Corporation focused on expanding access to transformative gene therapies for rare diseases. The company is dedicated to developing a one-time autologous hematopoietic stem cell gene therapy for adenosine deaminase severe combined immunodeficiency (ADA-SCID). Rarity aims to merge clinical validation with a public benefit mandate to enhance treatment access for patient

See plans & pricing → Track Rarity PBC’s funding, hiring, and signals — with verified contacts — on Fundz.